HOME >> BIOLOGY >> NEWS
Nanoparticle probes are destined for major new role in medical diagnostics and drug delivery

The emerging miniaturized world known as nanomedicine integrates technology, biology and medicine using tools and materials constructed from molecular- and atomic-sized particles too small to seen with a conventional laboratory microscope. Shuming Nie, PhD, professor of biomedical engineering at Emory University and the Georgia Institute of Technology, and director of cancer nanotechnology at Emory's Winship Cancer Institute, will highlight exciting technological breakthroughs in nanomedicine at the annual meeting of the American Association for the Advancement of Science (AAAS) in Seattle. Dr. Nie's talk on "Bioconjugated Nanoparticles for Personalized Medicine: Molecular Imaging, Profiling and Drug Targeting" will be part of a two-day Nanotechnology Seminar at the meeting.

The science of nanotechnology is rapidly moving from its early beginnings in electronics, computers and telecommunications into the expanding field of biomedical nanotechnology. Dr. Nie has been a leader in the nanomedicine field, and has developed semiconductor nanoparticles called quantum dots, which can be bound to particular genes and proteins and used as markers for molecular diagnostics and drug delivery.

"Biomedical nanotechnology is leading to major advances in molecular diagnostics, therapeutics, molecular biology and bioengineering," Dr. Nie says. "Scientists have begun to develop functional nanoparticles that are linked to biological molecules such as peptides, proteins and DNA."

By virtue of their miniature size nanoparticles assume special properties that distinguish them from larger particles, including the ability to emit light in different colors and to act as fluorescent tags. This makes them highly suitable as contrast agents for magnetic resonance imaging (MRI), positron emission tomography (PET) or as fluorescent tracers in optical microscopy. They also may be useful as structural scaffold in tissue engineering.

Although nanoparticles are similar
'"/>

Contact: Ron Sauder
rsauder@emory.edu
404-727-3366
Emory University Health Sciences Center
13-Feb-2004


Page: 1 2

Related biology news :

1. Nanoparticles illuminate brain tumors for days under MRI
2. Nanoparticles could aid biohazard detection, computer industry
3. Nanoparticles in air bad news for people
4. Microarrays, key genome expression trackers, work better when probes are sequence-verified
5. Study probes ecosystem of tree holes
6. UCLA chemists develop new coating for nanoscale probes
7. Shark guide probes uncharted waters
8. Purdue research suggests nanotubes could make better brain probes
9. Carnegie Mellon University receives NASA award to develop probes to detect life on Mars
10. MIT team probes arsenic and old lakes
11. MIT probes cartilage on nanoscale

Post Your Comments:
(Date:5/18/2015)... , May 18, 2015 Fingerprint ... sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one if ... June until and including Q3 2015 and the sensors will ... . Communicated order values for 2015 hereby amount to 740 ... Q1 2015 of 140 MSEK and a number of smaller ...
(Date:5/11/2015)... 2015 Curemark LLC, a privately held drug ... new Phase III double blind, randomized, placebo-controlled clinical trial ... on all children ages 3-8 with Autism. Previously, Curemark ... double blinded clinical trial for CM-AT in children ages ... digestive enzyme chymotrypsin. This new trial will help determine ...
(Date:5/5/2015)... , May 5, 2015, NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, reminds investors ... Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA ... 5-7, 2015. The three-day conference is organized ... is speaking in is themed Global Fraud: Where is ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
(Date:5/27/2015)... 2015 ­ Caris Life Sciences®, a leading ... medicine, today announced it has appointed the Levine Cancer ... excellence site in the Caris Centers of Excellence for ... Institute is one of the largest cancer care providers ... cancer patients annually. Derek Raghavan , M.D., Ph.D., ...
(Date:5/26/2015)... 2015 Regenestem Network has ... clinic in Buenos Aires, Argentina. The clinic will be ... specialist. Pastrana has assembled a multidisciplinary team of medical ... her state-of-the-art Puerto Madero office. , The new ... phase IV clinical studies in cellular therapies, and establish ...
(Date:5/26/2015)... 26, 2015 Innovacyn, a leader ... the human and animal health industries, announced today ... Innovators of Agriculture College Scholarship Award. The scholarship ... exhibits a passionate commitment to the agriculture industry ... year’s winners, Alexis Pedrow from Anderson County Jr/Sr ...
(Date:5/26/2015)... and HILDEN, Germany ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... its QIAGEN Clinical Insight ® (QCI™) bioinformatics ... to interpret and report on genomic variants identified ... applications for the bioinformatics platform are in oncology, ...
Breaking Biology Technology:Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 2Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 3Caris Life Sciences Designates Levine Cancer Institute as a Caris Center of Excellence 4Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 2Regenestem Network and Silvina Pastrana, M.D. Announce the Opening of a New Stem Cell Clinic in Buenos Aires 3Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 2Innovacyn Announces Winners Of This Year’s Vetericyn® College Scholarship Award 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5
Cached News: